Showing results (511-520 of 583) with videos related to

Sort By:
Pageof 59
Neuropharmacology|August 16, 2017
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplaceMichael H Baumann, Susruta Majumdar, Valerie Le Rouzic, et al.
Addiction Biology|February 4, 2021
Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre miceBree A Humburg, Chloe J Jordan, Hai-Ying Zhang, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Pharmacological Research|November 9, 2024
Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in miceMarthe M Vandeputte, Grant C Glatfelter, Donna Walther, et al.
Toxicology|July 7, 2024
Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male ratsNicholas Pintori, Maria Pina Serra, Antonio Carai, et al.
Chest|December 11, 2003
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologistsY C Gary Lee, Michael H Baumann, Nick A Maskell, et al.
International Journal of Oncology|June 22, 1999
Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cellsX Y Wen, A K Stewart, R R Sooknanan, et al.
Neuropharmacology|April 4, 2023
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needsFarah Z Zia, Michael H Baumann, Sean J Belouin, et al.
Drug and Alcohol Dependence|December 31, 2014
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterMaarten E A Reith, Bruce E Blough, Weimin C Hong, et al.
Drug Testing and Analysis|April 20, 2018
Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomersGavin McLaughlin, Michael H Baumann, Pierce V Kavanagh, et al.
Pageof 59